Skip to content

A study of adjuvant chemotherapy for malignant glioma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN81218776
Enrollment
600
Registered
2001-02-28
Start date
1988-09-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cancer Cancer

Interventions

1. One group receives chemotherapy added to a standard radiotherapy regimen 2. The other group receives none

Sponsors

Medical Research Council (MRC) (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-69 2. No previous treatment except surgery, corticosteroids, anticonvulsants or diuretics 3. Entry within 6 weeks of surgery 4. Other malignancies 5. Fitness for treatment

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Survival time

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026